Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats.

Several studies have shown functional improvements, neuroprotective, and neuroregenerative effects after mesenchymal stem cells transplantation to parkinsonian animal models. However, questions remain about the safety, feasibility, and long-term efficacy of this approach. In this study, we investigated migration, therapeutic, tumorigenesis, and epileptogenic effects of human umbilical cord mesenchymal stromal cells (HUMSCs) 1 year after transplantation into rotenone-induced hemiparkinsonian rats. Our data indicated that DiI-labeled HUMSCs migrated in the lesioned hemisphere, from corpus striatum (CPu) to substantia nigra. By integrating with host cells and differentiating into NSE, GFAP, Nestin, and tyrosine hydroxylase-positive cells, HUMSCs prevented 48.4% dopamine neurons from degeneration and 56.9% dopamine terminals from loss, both correlating with improvement of apomorphine-induced rotations. The CD50 and CD97 value of pentylenetetrazol and semiquantitative immunohistochemical analysis of proliferating cell nuclear antigen (PCNA), β-catenin, C-myc, and NF-κB expression showed no significant difference between HUMSCs transplanted and untransplanted groups, whereas the expressions of Bcl-2 and P53 in the grafted CPu were upregulated by 281% and 200% compared to ungrafted CPu. The results of this long-term study suggest that HUMSCs transplantation, 1 of the most potential treatments for Parkinson's disease, is an effective and safe approach.
AuthorsNian Xiong, Xuebing Cao, Zhentao Zhang, Jinsha Huang, Chunnuan Chen, Zhaowen Zhang, Min Jia, Jing Xiong, Zhihou Liang, Shenggang Sun, Zhicheng Lin, Tao Wang
JournalBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation (Biol Blood Marrow Transplant) Vol. 16 Issue 11 Pg. 1519-29 (Nov 2010) ISSN: 1523-6536 [Electronic] United States
PMID20542126 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 American Society for Blood and Marrow Transplantation. All rights reserved.
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Carbocyanines
  • Grap protein, human
  • Intermediate Filament Proteins
  • NES protein, human
  • Neoplasm Proteins
  • Nerve Tissue Proteins
  • Nes protein, rat
  • Nestin
  • Rotenone
  • 3,3'-dioctadecylindocarbocyanine
  • Tyrosine 3-Monooxygenase
  • Phosphopyruvate Hydratase
  • Apomorphine
  • Pentylenetetrazole
  • Adaptor Proteins, Signal Transducing (metabolism)
  • Animals
  • Apomorphine (pharmacology)
  • Brain (drug effects)
  • Carbocyanines (metabolism)
  • Cell Differentiation (physiology)
  • Cell Movement (physiology)
  • Corpus Striatum (cytology, metabolism)
  • Dose-Response Relationship, Drug
  • Epilepsy (chemically induced)
  • Female
  • Humans
  • Intermediate Filament Proteins (metabolism)
  • Locomotion (drug effects)
  • Mesenchymal Stem Cell Transplantation (adverse effects, methods)
  • Mesenchymal Stromal Cells (cytology, metabolism)
  • Neoplasm Proteins (metabolism)
  • Nerve Tissue Proteins (metabolism)
  • Nestin
  • Neurons (cytology, metabolism)
  • Parkinsonian Disorders (chemically induced, therapy)
  • Pentylenetetrazole (pharmacology)
  • Phosphopyruvate Hydratase (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Rotation
  • Rotenone (pharmacology)
  • Staining and Labeling (methods)
  • Substantia Nigra (cytology, metabolism)
  • Treatment Outcome
  • Tyrosine 3-Monooxygenase (metabolism)
  • Umbilical Cord (cytology)
  • Ventral Tegmental Area (cytology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: